logo
episode-header-image
Jul 1
31m 58s

Episode 60: How to make money from medic...

Dr. Felix Beacher
About this episode

Under capitalism a company has to make money. But a big problem in medical AI is that few companies are. Most are burning up venture capital and profitability is very hard to achieve. A key reason is that it is extremely difficult to obtain government reimbursement for the use of medical AI products. But a small number of companies are making progress here. What can learned from them? And how would a shift in reimbursement change the sector?

Up next
Jun 30
Episode 60: How to make money from medical AI, with Chris Wood, CEO of RevealDX
Under capitalism a company has to make money. Buta big problem in medical AI is that few companies are. Mostare burning up venture capital and profitability is very hard to achieve. A key reason is that it is extremely difficult to obtain government reimbursement for the use of m ... Show More
33m 6s
Jun 16
Episode 59: How is AI changing pathology? With Imogen Fitt of Signify Research
Microscopic analysis of tissue slides, or pathology, is a vital diagnostic tool. It can determine disease type and stage and it remains the gold standard approach for diagnostics in cancer. But the process is labor-intensive and dependent on the skill of the pathologist. AI techn ... Show More
31m 26s
May 28
Episode 58: AI hallucinations and the dangers for healthcare, with Vlad Panin CEO of iFrame
We are all aware now of the outrageous power of Large language Models, or LLMs, such as Grok, Gemini and chatGTP. And ever since they exploded onto the scene in late 2022 there has been a scramble to implement them into health care products. However there’s a big problem. They ca ... Show More
32m 59s
Recommended Episodes
Jul 2024
ALS Patients Take on the FDA
ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. Howeve ... Show More
47m 41s
Apr 29
Interview: 3 reasons why medications are so expensive in the US | Kiah Williams
A century after its discovery, insulin remain essential in treating diabetes, and has a relatively low production cost, with a vial generally costing less than $6 to make. But those in the US pay on average 10 times more than those in other countries— leading some patients to tak ... Show More
28m 56s
Mar 2023
Accelerating Hope: The Pathway for Cures
When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threaten ... Show More
23 m
Apr 2024
How AI is Accelerating the Search for New Medicines
Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ... Show More
23m 25s
May 2024
Tom Mueller, "How to Make a Killing: Blood, Death and Dollars in American Medicine" (Norton, 2023)
Dialysis is a medical miracle, a treatment that allows people with kidney failure to live when otherwise they would die. It also provides a captive customer for the dialysis industry, which values the steady revenues that come from critically required long-term care that is guara ... Show More
1h 9m
Jul 2024
#377 — The Future of Psychedelic Medicine 2
Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic stress disor ... Show More
1h 16m
May 13
Why Do Americans Pay So Much for Drugs?
On Monday, President Donald Trump signed an executive order telling drugmakers to slash the prices of their medicines. Once again, the president showed an amazing nose for interesting questions. Statistically, the U.S. accounts for 4 percent of the world’s population but nearly 5 ... Show More
1h 9m
Aug 2024
The Wild West of Ketamine Treatment
New developments in actor Matthew Perry’s death are shining a light on the ethics and efficacy of using ketamine as a therapeutic drug. To learn more about the promise and pitfalls of ketamine treatment, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta turns to David Feifel, on ... Show More
35m 13s
Aug 2024
KIR With Jillian Michaels Hot Takes: Are Beta Blockers the new “Telehealth” IT drug?
With good healthcare becoming harder to find, and afford, more and more people are turning to Telehealth medicine to get their prescriptions. Generally this type of online Doc has been associated with the trendier drugs with sexy promises. From “boner pills” to weight loss drugs, ... Show More
6m 31s
Jun 11
Will AI Finally Defeat Chronic Diseases Like Alzheimer’s?
The pharmaceutical industry has yet to develop highly effective treatments for common chronic and neurological issues, like Alzheimer’s and cardiovascular disease. But GenAI promises to accelerate the discovery and development of breakthrough treatments. BCG’s Priya Chandran expl ... Show More
28m 43s